Paul de Laat

742 citations

21 papers · 554 indexed · h-index 15

Co-authors: Jan Smeıtınk Mirian C. H. Janssen Saskia Koene Richard J. Rodenburg Coriene E. Catsman‐Berrevoets Annick S. Devos Marry M. van den Heuvel‐Eibrink M.L. te Winkel
Topics: Mitochondrial Function and Pathology (15 papers)Metabolism and Genetic Disorders (10 papers)ATP Synthase and ATPases Research (9 papers)
Cited by: Clinical Biochemistry Rheumatology Molecular Biology
Journals: Neurology Ophthalmology Annals of Oncology
Partner nations: Netherlands Israel United Kingdom

In The Last Decade

Paul de Laat

21 papers receiving 544 citations

Peers

Countries citing papers authored by Paul de Laat

Since Specialization

Citations

This map shows the geographic impact of Paul de Laat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul de Laat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul de Laat more than expected).

Fields of papers citing papers by Paul de Laat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul de Laat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul de Laat. The network helps show where Paul de Laat may publish in the future.

Co-authorship network of co-authors of Paul de Laat

This figure shows the co-authorship network connecting the top 25 collaborators of Paul de Laat. A scholar is included among the top collaborators of Paul de Laat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul de Laat. Paul de Laat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identifying trajectories of fatigue in patients with primary mitochondrial disease due to the m.3243A > G variant 2022 ·Journal of Inherited Metabolic Disease ·(unknown),C.M. Verhaak,Jan Smeıtınk,Paul de Laat,Mirian C. H. Janssen,José A. E. Custers	3
2	One mutation, three phenotypes: novel metabolic insights on MELAS, MIDD and myopathy caused by the m.3243A > G mutation 2021 ·Metabolomics ·(unknown),Jeremie Zander Lindeque,Shayne Mason,Francois H. van der Westhuizen,Richard J. Rodenburg,Paul de Laat,Jan Smeıtınk,Mirian C. H. Janssen,Roan Louw	16
3	Six-year prospective follow-up study in 151 carriers of the mitochondrial DNA 3243 A>G variant 2020 ·Journal of Medical Genetics ·Paul de Laat,Richard J. Rodenburg,Nel Roeleveld,Saskia Koene,Jan Smeıtınk,Mirian C. H. Janssen	19
4	Five non-mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes phenotype adult patients with m.3243A>G mutation after kidney transplantation: follow-up and review of the literature 2019 ·Clinical Kidney Journal ·Paul de Laat,(unknown),Jack F.M. Wetzels,Jan Smeıtınk,Mirian C. H. Janssen	15
5	Fear of disease progression in carriers of the m.3243A > G mutation 2018 ·Orphanet Journal of Rare Diseases ·José A. E. Custers,Paul de Laat,Saskia Koene,Jan Smeıtınk,Mirian C. H. Janssen,C.M. Verhaak	8
6	A urinary biosignature for mitochondrial myopathy, encephalopathy, lactic acidosis and stroke like episodes (MELAS) 2018 ·Mitochondrion ·(unknown),Jeremie Zander Lindeque,Shayne Mason,Francois H. van der Westhuizen,Anu Suomalainen,Anna H. Hakonen,Christopher J. Carroll,Richard J. Rodenburg,Paul de Laat,Mirian C. H. Janssen,Jan Smeıtınk,Roan Louw	16
7	Intra‐patient variability of heteroplasmy levels in urinary epithelial cells in carriers of the m.3243A>G mutation 2018 ·Molecular Genetics & Genomic Medicine ·Paul de Laat,Richard J. Rodenburg,Jan Smeıtınk,Mirian C. H. Janssen	12
8	Quantification of gait in mitochondrial m.3243A > G patients: a validation study 2017 ·Orphanet Journal of Rare Diseases ·(unknown),Saskia Koene,Jan T. Groothuis,Paul de Laat,Mirian C. H. Janssen,Jan Smeıtınk	4
9	Is 2D speckle tracking echocardiography useful for detecting and monitoring myocardial dysfunction in adult m.3243A>G carriers? — a retrospective pilot study 2017 ·Journal of Inherited Metabolic Disease ·Saskia Koene,Jean‐Pierre Timmermans,Gert Weijers,Paul de Laat,Chris L. de Korte,Jan Smeıtınk,Mirian C. H. Janssen,Livia Kapusta	3
10	Quality of life, fatigue and mental health in patients with the m.3243A > G mutation and its correlates with genetic characteristics and disease manifestation 2016 ·Orphanet Journal of Rare Diseases ·C.M. Verhaak,Paul de Laat,Saskia Koene,Marijke Tibosch,Richard J. Rodenburg,Imelda J. M. de Groot,Hans Knoop,Mirian C. H. Janssen,Jan Smeıtınk	14
11	Three families with ‘de novo’ m.3243A>G mutation 2016 ·PubMed ·Paul de Laat,Mirian C. H. Janssen,Charlotte L. Alston,Robert W. Taylor,Richard J. Rodenburg,Jan Smeıtınk	14
12	Obstetric complications in carriers of the m.3243A>G mutation, a retrospective cohort study on maternal and fetal outcome 2015 ·Mitochondrion ·Paul de Laat,(unknown),Mireille N. Bekker,Jan Smeıtınk,Mirian C. H. Janssen	28
13	Serum GDF15 Levels Correlate to Mitochondrial Disease Severity and Myocardial Strain, but Not to Disease Progression in Adult m.3243A>G Carriers 2015 ·JIMD Reports ·Saskia Koene,Paul de Laat,(unknown),Gert Weijers,Dennis Vriens,Fred C.G.J. Sweep,Janneke Timmermans,Livia Kapusta,Mirian C. H. Janssen,Jan Smeıtınk	34
14	Dysphagia, malnutrition and gastrointestinal problems in patients with mitochondrial disease caused by the m3243A>G mutation. 2015 ·PubMed ·Paul de Laat,H. Zweers,Simone Knuijt,Jan Smeıtınk,Geert Wanten,Mirian C. H. Janssen	23
15	Migratory polyarthritis as an adverse effect of thiamazole use in a 13-year-old girl with Graves’ disease 2015 ·Journal of Pediatric Endocrinology and Metabolism ·(unknown),Paul de Laat,Jos Draaisma	2
16	Serum FGF21 levels in adult m.3243A>G carriers 2014 ·Neurology ·Saskia Koene,Paul de Laat,(unknown),Dennis Vriens,(unknown),Fred C.G.J. Sweep,Richard J. Rodenburg,A. Rogier T. Donders,Mirian C. H. Janssen,Jan Smeıtınk	31
17	Mitochondrial Retinal Dystrophy Associated with the m.3243A>G Mutation 2013 ·Ophthalmology ·Paul de Laat,Jan Smeıtınk,Mirian C. H. Janssen,Jan E.E. Keunen,Camiel J.F. Boon	61
18	Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A > G mutation 2012 ·Journal of Inherited Metabolic Disease ·Paul de Laat,Saskia Koene,(unknown),Richard J. Rodenburg,Mirian C. H. Janssen,Jan Smeıtınk	105
19	Inheritance of the m.3243A>G mutation 2012 ·JIMD Reports ·Paul de Laat,Saskia Koene,(unknown),Richard J. Rodenburg,Mirian C. H. Janssen,Jan Smeıtınk	17
20	Posterior reversible encephalopathy syndrome in childhood cancer 2010 ·Annals of Oncology ·Paul de Laat,M.L. te Winkel,Annick S. Devos,Coriene E. Catsman‐Berrevoets,Rob Pieters,Marry M. van den Heuvel‐Eibrink	83

About Paul de Laat

Paul de Laat is a scholar working on Clinical Biochemistry, Nephrology and Molecular Biology, having authored 21 papers that have together received 554 indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (15 papers), Metabolism and Genetic Disorders (10 papers) and ATP Synthase and ATPases Research (9 papers). The work is most often cited by research in Clinical Biochemistry (228 citations), Rheumatology (99 citations) and Molecular Biology (391 citations). Paul de Laat has collaborated with scholars based in Netherlands, Israel and United Kingdom. Frequent co-authors include Jan Smeıtınk, Mirian C. H. Janssen, Saskia Koene, Richard J. Rodenburg, Coriene E. Catsman‐Berrevoets, Annick S. Devos, Marry M. van den Heuvel‐Eibrink, M.L. te Winkel, Rob Pieters and Jan E.E. Keunen. Their work appears in journals such as Neurology, Ophthalmology and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact